You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美單日新增11.37萬宗新冠 輝瑞提交小童接種「復必泰」臨牀數據
阿思達克 09-29 15:42
美國新冠疫情緩和。據美國約翰霍普金斯大學網站數據,截至美國時間午夜(本港時間下午3時),美國累計新冠確診43,230,197宗,單日新增113,749宗。累計死亡個案693,055宗,單日增加2,621宗。 《今日美國報》報道,美國輝瑞及BioNTech藥廠已向美國食品及藥物管理局提交5至11歲小童接種「復必泰」的臨牀測試數據。公司計劃在數據顯示有效及安全下,向當局提出緊急使用申請。小童接種劑量爲成年人的三分一。 另外,上週末有逾40萬名合資格美國民衆接種第三劑新冠疫苗,白宮新冠協調官Jeff Zients表示,有額外100萬名合資格人士已預約安排接種第三劑疫苗。美國食品及藥物管理局早前批準65歲或以上高危羣組人士接種第三劑疫苗,涵蓋人口約2,500萬。 以下爲過去七日美國每日新冠疫情統計: 日期│累計確診│單日新增確診│累計死亡│單日新增死亡 9月28日(二)│43,230,197宗│+113,749宗│693,055宗│+2,621宗 9月27日(一)│43,116,448宗│+185,040宗│690,434宗│+2,401宗 9月26日(日)│42,931,408宗│淨剔除9,050宗│688,033宗│+282宗 9月25日(六)│42,940,458宗│+ 86,854宗│687,751宗│+667宗 9月24日(五)│42,853,604宗│+181,313宗│687,084宗│+2,727宗 9月23日(四)│42,672,291宗│+127,172宗│684,357宗│+3,160宗 9月22日(三)│42,545,119宗│+131,634宗│681,197宗│+2,695宗
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account